Calls
1
Teresa Graham
CEO, Roche Pharmaceuticals
Win Rate
100.0%
return
+2.5%
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 13
$53.28
+2.5%
Roche's breast cancer pipeline delivered positive interim data for a hormone receptor-positive breast cancer therapy, which represents about 80% of breast cancer cases. The drug is oral, highly tolerable, and as effective as current standards at interim analysis, positioning Roche to establish a new standard of care in a large indication where patients remain on treatment for years.
Pharma & Biotech
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
Teresa Graham has 1 trade ideas tracked on Buzzberg across 1 tickers since January 2026. Most covered: RHHBY.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
